S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome

NCT00016419 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

130

Enrollment

NETWORK

Sponsor class

Conditions

Leukemia
Myelodysplastic Syndromes

Interventions

BIOLOGICAL: anti-thymocyte globulin
DRUG: cyclosporine

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]